Life sciences: New investment fund launched in Montreal in cooperation with Munich-based TVM Capital


A new venture capital fund with Canadian, American and European investors is launched in Montreal. With a starting volume of at least 150 million dollars, this will be Canada's biggest investment fund in life sciences. The principal investor is Teralys Capital, the venture capital reservoir of 700 million dollars created jointly by Investissement Québec, Caisse des dépôts and Fonds de solidarité FTQ.

The new investment fund was registered August 18, 2011, on the Quebec companies register under the name TVM Capital Life Science VII. The register also indicates that on top of Teralys, TVM Capital, a German venture capital fund, and Eli Lilly, an American pharmaceutical company, are participating.

TVM, which stands for Techno Venture Manager, is a German fund created in 1983 with more than 250 investments, 120 of which in life science companies. To this day, its Life Sciences division manages a little over 1 bn $ in investments. The principal fund manager of the Life Science division, Mr. Hubert Birner, relocated to Montreal to manage the new fund from there.

Source & more: affaires.lapresse.ca